Cargando…

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges

Graft-versus-host disease (GVHD) is the leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Immunomodulation using regulatory T cells (Tregs) offers an exciting option to prevent and/or treat GVHD as these cells naturally function to maintai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hefazi, Mehrdad, Bolivar-Wagers, Sara, Blazar, Bruce R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469916/ https://www.ncbi.nlm.nih.gov/pubmed/34575843 http://dx.doi.org/10.3390/ijms22189676

Ejemplares similares

Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
por: Hippen, Keli L., et al.
Publicado: (2018)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
por: Mohamed, Fathima A., et al.
Publicado: (2021)

Novel regulatory therapies for prevention of Graft-versus-host disease
por: Leventhal, Joseph, et al.
Publicado: (2012)

Editorial: Regulatory T cells in graft versus host disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2023)

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host Disease
por: Ramlal, Reshma, et al.
Publicado: (2017)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease
por: Mancusi, Antonella, et al.
Publicado: (2018)

The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease
por: Beres, Amy J., et al.
Publicado: (2013)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death
por: Logan, Brent R., et al.
Publicado: (2023)

Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
por: Trzonkowski, Piotr, et al.
Publicado: (2013)

Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
por: Hefazi, Mehrdad, et al.
Publicado: (2018)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)

Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells
por: Monlish, Darlene A., et al.
Publicado: (2021)

Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
por: Zhang, Lingling, et al.
Publicado: (2018)

Recent advances in ocular graft-versus-host disease
por: Cheng, Xianjing, et al.
Publicado: (2023)

Ruxolitinib for Therapy of Graft-versus-Host Disease
por: Neumann, Thomas, et al.
Publicado: (2019)

Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease
por: Levy, Robert B., et al.
Publicado: (2021)

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
por: Pusic, Iskra, et al.
Publicado: (2019)

Third-party regulatory T cells prevent murine acute graft-versus-host disease
por: Lim, Jung-Yeon, et al.
Publicado: (2018)

Regulatory T Cells and Ocular Graft Versus Host Disease: A Novel Treatment Approach
por: Pishnamaz, Mohammad Reza, et al.
Publicado: (2018)

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2022)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Mouse models of graft-versus-host disease: advances and limitations
por: Schroeder, Mark A., et al.
Publicado: (2011)

Translational and clinical advances in acute graft-versus-host disease
por: Gooptu, Mahasweta, et al.
Publicado: (2020)

Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control
por: Nicholls, Jemma, et al.
Publicado: (2021)

Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
por: Betts, Brian C., et al.
Publicado: (2019)

Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021)

Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2022)

IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease
por: Dwyer, Gaelen K., et al.
Publicado: (2022)

Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells
por: Park, Min-Jung, et al.
Publicado: (2020)

Regulatory T-cell therapy in Crohn’s disease: challenges and advances
por: Clough, Jennie N, et al.
Publicado: (2020)

Novel therapies for graft versus host disease with a focus on cell therapies
por: Zeiser, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gvmm85uilptc5j7ad36hlk9v3t